The Trump administration has rejected a request from Massachusetts that state officials argued would have given them more flexibility over its Medicaid program and greater negotiating power over drug companies. The state’s Health and Human Services department asked the administration to approve a plan that would have allowed the state to limit what drugs would be covered in its Medicaid program. Currently, states are required to cover almost all drugs approved by the Food and Drug Administration, but states are looking for new ways to cut down drug prices as Medicaid costs continue to eat up state budgets. (Jessie Hellmann, The Hill)
